Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
306
-
Total 13F shares, excl. options
-
69.4M
-
Shares change
-
+222K
-
Total reported value, excl. options
-
$5.33B
-
Value change
-
+$77.9M
-
Put/Call ratio
-
0.56
-
Number of buys
-
141
-
Number of sells
-
-131
-
Price
-
$76.73
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q4 2020
354 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q4 2020.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.4M shares
of 139M outstanding shares and own 50.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.6M shares), VANGUARD GROUP INC (9.28M shares), STATE STREET CORP (3.93M shares), Johnson & Johnson Innovation - JJDC, Inc. (3.26M shares), Invesco Ltd. (3.26M shares), JPMORGAN CHASE & CO (2.41M shares), GEODE CAPITAL MANAGEMENT, LLC (1.61M shares), NORTHERN TRUST CORP (1.56M shares), CREDIT SUISSE AG/ (1.51M shares), and FMR LLC (1.42M shares).
This table shows the top 306 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.